AP3480A - Phosphaplatins and their use for treatment of cancers - Google Patents

Phosphaplatins and their use for treatment of cancers

Info

Publication number
AP3480A
AP3480A AP2012006594A AP2012006594A AP3480A AP 3480 A AP3480 A AP 3480A AP 2012006594 A AP2012006594 A AP 2012006594A AP 2012006594 A AP2012006594 A AP 2012006594A AP 3480 A AP3480 A AP 3480A
Authority
AP
ARIPO
Prior art keywords
phosphaplatins
cancers
treatment
Prior art date
Application number
AP2012006594A
Other languages
English (en)
Other versions
AP2012006594A0 (en
Inventor
Rathindra N Bose
Original Assignee
Univ Ohio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44627266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3480(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Ohio filed Critical Univ Ohio
Publication of AP2012006594A0 publication Critical patent/AP2012006594A0/xx
Application granted granted Critical
Publication of AP3480A publication Critical patent/AP3480A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AP2012006594A 2010-06-04 2011-06-02 Phosphaplatins and their use for treatment of cancers AP3480A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35151410P 2010-06-04 2010-06-04
PCT/US2011/038948 WO2011153365A1 (en) 2010-06-04 2011-06-02 Phosphaplatins and their use for treatment of cancers

Publications (2)

Publication Number Publication Date
AP2012006594A0 AP2012006594A0 (en) 2012-12-31
AP3480A true AP3480A (en) 2015-12-31

Family

ID=44627266

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006594A AP3480A (en) 2010-06-04 2011-06-02 Phosphaplatins and their use for treatment of cancers

Country Status (30)

Country Link
US (4) US9688709B2 (pt)
EP (1) EP2575802B1 (pt)
JP (1) JP5860872B2 (pt)
KR (1) KR101775410B1 (pt)
CN (6) CN108392490A (pt)
AP (1) AP3480A (pt)
AU (1) AU2011261381B2 (pt)
BR (1) BR112012030927B1 (pt)
CA (1) CA2800898C (pt)
CL (1) CL2012003416A1 (pt)
CO (1) CO6640302A2 (pt)
CY (1) CY1118466T1 (pt)
DK (1) DK2575802T3 (pt)
EA (1) EA021526B1 (pt)
ES (1) ES2606855T3 (pt)
HR (1) HRP20170225T1 (pt)
HU (1) HUE030249T2 (pt)
IL (1) IL223405B (pt)
LT (1) LT2575802T (pt)
MX (1) MX2012014174A (pt)
MY (1) MY162902A (pt)
NZ (1) NZ603952A (pt)
PL (1) PL2575802T3 (pt)
PT (1) PT2575802T (pt)
RS (1) RS55714B1 (pt)
SG (1) SG185722A1 (pt)
SI (1) SI2575802T1 (pt)
SM (1) SMT201700056B (pt)
WO (1) WO2011153365A1 (pt)
ZA (1) ZA201209007B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP3480A (en) 2010-06-04 2015-12-31 Univ Ohio Phosphaplatins and their use for treatment of cancers
JP2014502634A (ja) * 2011-01-12 2014-02-03 オハイオ ユニバーシティー 抗血管新生、抗転移、及びアポトーシス促進の特性を有するホスファプラチン並びにそれらの使用
CA2851254A1 (en) * 2011-10-05 2013-04-11 Shadi MOGHADDAS Efficient processes for large scale preparation of phophaplatins antitumor agents
JP6027619B2 (ja) * 2011-10-05 2016-11-16 ラシンドラ・エヌ・ボーズ ホスファプラチン系抗腫瘍剤の大規模調製のための効率的プロセス
IN2014KN02722A (pt) * 2012-05-24 2015-05-08 Phosplatin Therapeutics Llc
US9333211B2 (en) * 2013-02-22 2016-05-10 University Of Houston System Phosphaplatin mediated modulation of pigment epithelial derived factor and uses thereof
EP3107534A4 (en) * 2014-02-19 2017-09-06 The University Of Houston System Compositions and methods for the treatment of neurodegenerative diseases
WO2017176880A1 (en) * 2016-04-06 2017-10-12 Phosplatin Therapeutics Llc Phosphaplatin liquid formulations
EP3565561A4 (en) 2017-01-06 2020-08-26 Phosplatin Therapeutics LLC PHOSPHAPLATIN COMPOUNDS AS THERAPEUTICS FOR THE TREATMENT OF BONE / BLOOD CANCER
AU2018327339B2 (en) * 2017-09-08 2023-10-12 Promontory Therapeutics Inc. Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof
JP2023547835A (ja) * 2020-10-20 2023-11-14 プロモントリー・セラピューティクス・インコーポレイテッド 高解糖性腫瘍細胞を選択的に標的化する治療剤としてのホスファプラチン化合物及びその方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009021081A2 (en) * 2007-08-06 2009-02-12 Ohio University Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291027A (en) 1979-03-07 1981-09-22 Engelhard Minerals & Chemicals Corp. Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
US4234500A (en) 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
CA2017739A1 (en) 1989-07-18 1991-01-18 Leslie S. Hollis Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
AUPR330201A0 (en) 2001-02-23 2001-03-22 University Of Sydney, The Metal complexes and therapeutic uses thereof
DE10314780A1 (de) 2003-03-19 2004-09-30 Ktb Tumorforschungsgesellschaft Mbh Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden
CA2524478A1 (en) 2003-05-02 2004-11-18 Aronex Pharmaceuticals, Inc. Lipid platinum complexes and methods of use thereof
EP1644388A2 (en) 2003-06-27 2006-04-12 ODANI, Akira Bisphosphonate complexes
US20110034714A1 (en) 2007-07-06 2011-02-10 Hisao Ekimoto Metal complex compound, cancer therapeutic agent composition containing the metal complex compound as an active ingredient, and intermediate for the metal complex compound
WO2011125911A1 (ja) 2010-03-31 2011-10-13 国立大学法人金沢大学 金属錯体およびこれを有効成分として含有する抗がん剤
AP3480A (en) 2010-06-04 2015-12-31 Univ Ohio Phosphaplatins and their use for treatment of cancers
JP2014502634A (ja) 2011-01-12 2014-02-03 オハイオ ユニバーシティー 抗血管新生、抗転移、及びアポトーシス促進の特性を有するホスファプラチン並びにそれらの使用
JP6027619B2 (ja) * 2011-10-05 2016-11-16 ラシンドラ・エヌ・ボーズ ホスファプラチン系抗腫瘍剤の大規模調製のための効率的プロセス

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009021081A2 (en) * 2007-08-06 2009-02-12 Ohio University Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOSE RATHINDRA N ET AL: "Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 105, no. 47, 25 November 2008 (2008-11-25), pages 18314 - 18319,1292 *
MISHUR ROBERT J ET AL: "Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.", INORGANIC CHEMISTRY, vol. 47, no. 18, 15 September 2008 (2008-09-15), pages 7972 - 7982 *

Also Published As

Publication number Publication date
HRP20170225T1 (hr) 2017-04-07
ES2606855T3 (es) 2017-03-28
US20130064902A1 (en) 2013-03-14
EP2575802A1 (en) 2013-04-10
BR112012030927B1 (pt) 2021-09-21
MY162902A (en) 2017-07-31
MX2012014174A (es) 2013-07-03
PT2575802T (pt) 2016-12-27
US20190315789A1 (en) 2019-10-17
US10385083B2 (en) 2019-08-20
CO6640302A2 (es) 2013-03-22
CN108186651A (zh) 2018-06-22
CN108409795A (zh) 2018-08-17
BR112012030927A2 (pt) 2017-12-05
CN108299508A (zh) 2018-07-20
CN108409795B (zh) 2024-09-27
HUE030249T2 (en) 2017-04-28
NZ603952A (en) 2014-07-25
JP5860872B2 (ja) 2016-02-16
ZA201209007B (en) 2013-08-28
CA2800898C (en) 2018-12-04
CN108392490A (zh) 2018-08-14
JP2013529219A (ja) 2013-07-18
KR20130095244A (ko) 2013-08-27
CY1118466T1 (el) 2017-07-12
CN103037859A (zh) 2013-04-10
US10364264B2 (en) 2019-07-30
CA2800898A1 (en) 2011-12-08
WO2011153365A1 (en) 2011-12-08
US9688709B2 (en) 2017-06-27
US20170327521A1 (en) 2017-11-16
IL223405B (en) 2018-11-29
AU2011261381B2 (en) 2015-04-02
EA021526B1 (ru) 2015-07-30
AU2011261381A1 (en) 2013-01-10
CL2012003416A1 (es) 2013-09-06
SI2575802T1 (sl) 2017-03-31
EP2575802B1 (en) 2016-11-16
PL2575802T3 (pl) 2017-04-28
DK2575802T3 (en) 2017-01-09
US10759820B2 (en) 2020-09-01
KR101775410B1 (ko) 2017-09-06
LT2575802T (lt) 2016-12-27
SMT201700056B (it) 2017-03-08
EA201270812A1 (ru) 2013-05-30
RS55714B1 (sr) 2017-07-31
AP2012006594A0 (en) 2012-12-31
SG185722A1 (en) 2013-01-30
US20170327522A1 (en) 2017-11-16
CN108210516A (zh) 2018-06-29

Similar Documents

Publication Publication Date Title
IL276362A (en) Cancer treatment methods
IL248530A0 (en) Biomarkers and treatment methods
HRP20170225T1 (hr) Fosfoplatini i njihova uporaba za liječenje karcinoma
HRP20171352T1 (hr) Wnt-antagonisti i postupci liječenja
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
SG10201508495VA (en) Combination treatment of cancer
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
EP2539005A4 (en) ORAL PIECE AND METHODS OF USING THE SAME
ZA201300218B (en) Treatment of blood cancer
HK1189272A1 (zh) 治療癌症的方法
EP2574172A4 (en) MATERIALS AND METHOD FOR TREATING INFLAMMATION
IL256026B (en) Treatment methods
EP2640390A4 (en) METHODS OF TREATING CANCER
EP2547368A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
EP2709730A4 (en) TREATMENT AND PROGNOSIS OF CANCER
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
EP2574194A4 (en) MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
GB201017354D0 (en) Treatment of cancer
GB201017356D0 (en) Combination treatment of cancer
GB201002499D0 (en) Treatment of tumours
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer
ZA201301175B (en) Biomarkers and methods of treatment